Filana Therapeutics (FLNA) Other Accumulated Expenses (2010 - 2026)

Filana Therapeutics' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $121000.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 23.9% year-over-year to $121000.0; the TTM figure through Jun 2026 stood at $121000.0 (down 23.9% YoY), while the FY2025 annual figure was $198000.0, down 33.78% from the prior year.
• Other Accumulated Expenses for Q2 2026 stood at $121000.0, up from $75000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $492000.0 in Q4 2022, with the low at $75000.0 in Q1 2026.
• The 5-year median for Other Accumulated Expenses is $244500.0 (2022), against an average of $257111.1.
• The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses surged 640.0% in 2022, then plunged 33.78% in 2025.
• Filana Therapeutics' Other Accumulated Expenses stood at $492000.0 in 2022, then declined by 21.75% to $385000.0 in 2023, then dropped by 22.34% to $299000.0 in 2024, then slumped by 33.78% to $198000.0 in 2025, then slumped by 38.89% to $121000.0 in 2026.
• Business Quant data shows FLNA's Other Accumulated Expenses at $121000.0 in Q2 2026, $75000.0 in Q1 2026, and $198000.0 in Q4 2025.